| 1 |
CI- -channel is essential for LDL-induced cell proliferation via the activation of Erk1/2 and PI3K/Akt and the upregulation of Egr-1 in human aortic smooth muscle cells /
Kyung Sun Heo;
S W Ryoo;
L Kim;
Mi-Young Nam;
S T Baek;
Hye Mi Lee;
Ah-Reum Lee;
Song Kyu Park;
Young Woo Park;
C S Myung;
Dong Uk Kim;
Kwang Lae Hoe
, 2008
|
| 2 |
Hirsutenone directly targets PI3K and ERK to inhibit adipogenesis in 3T3-L1 preadipocytes /
L Y Cheong;
S Suk;
N R Thimmegowda;
M Y Chung;
H Yang;
S G Seo;
B Shwetha;
J E Kim;
J Y Kwon;
Bo Yeon Kim;
K W Lee
, 2015
|
| 3 |
The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancer /
K S Park;
H Yang;
J Choi;
S Seo;
D Kim;
Chang Hoon Lee;
H Jeon;
S W Kim;
D H Lee
, 2017
|
| 4 |
Induction of Mac-2BP by nerve growth factor is regulated by the PI3K/Akt/NF-kappaB-dependent pathway in the HEK293 cell line /
Yuk-Pheel Park;
Seung-Chul Choi;
Bo Yeon Kim;
Jong-Tae Kim;
Eun Young Song;
S H Kang;
D Y Yoon;
S G Paik;
K D Kim;
J W Kim;
Hee Gu Lee
, 2008
|
| 5 |
Neuropeptide Y mitigates ER stress？induced neuronal cell death by activating the PI3K？XBP1 pathway /
Do Yeon Lee;
Seung Hyun Hong;
B Kim;
D S Lee;
Kweon Yu;
Kyu-Sun Lee
, 2018
|
| 6 |
Role of PI3k/MAPK signaling in the maintenance of human ESC self-renewal /
Kyu Won Lee;
Jin Yong Yook;
Yeesook Cho
, 2007
|
| 7 |
Synergistic anticancer efficacy of MEK inhibition and dual PI3K/mTOR inhibition in castration-resistant prostate cancer /
H Park;
Y Kim;
J W Sul;
I G Jeong;
H J Yi;
J B Ahn;
Jong Soon Kang;
Ji Eun Yun;
J J Hwang;
C S Kim
, 2015
|
| 8 |
TLR4 (toll-like receptor 4) activation suppresses autophagy through inhibition of FOXO3 and impairs phagocytic capacity of microglia /
J W Lee;
H Nam;
L E Kim;
Y Jeon;
H Min;
S Ha;
Y Lee;
Seon-Young Kim;
S J Lee;
E K Kim;
S W Yu
, 2019
|
Item
Results : 1-8 of 8.
